Search results
Results From The WOW.Com Content Network
Over the last 25 years, (ED) medications such as Viagra and others have become common and normal pieces of bedroom tool kit. These little pills have helped hundreds of millions of men all over the ...
A few medications have been proven to increase sex drive or improve aspects of sexual function in men, including ED medications, over-the-counter and prescription drugs for premature ejaculation ...
Mesterolone. Mesterolone, sold under the brand name Proviron among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels. [2] [3] It has also been used to treat male infertility, although this use is controversial. [2] [4] [5] It is taken by mouth.
Erectile dysfunction ( ED ), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity. It is the most common sexual problem in males and can cause psychological ...
Sold as Stendra, avanafil is a newer treatment that provides relief from ED for up to six hours, with a lower risk of side effects than other oral ED medications. Chewable ED medications.
Sildenafil, sold under the brand name Viagra, among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. [4] [8] It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. [9]
Viagra and Revatio are the drug’s brand names. Viagra doses range from 25 to 100 milligrams (mg). A typical starting dose of Viagra or sildenafil dosage is 50 milligrams. Whether you use ...
These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, but gynecomastia is generally reported to occur in 70 to 80% of patients. In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide monotherapy.